Vaccinia virus RNA polymerase associated with nuclei of infected HeLa cells.
Though vaccinia virus DNA and RNA replication take place predominantly in the cytoplasm of an infected cell, virus formation requires the presence of a functional nucleus in a yet undefined manner. When the nuclei from cells infected for 3 h are isolated and purified, they are found to synthesize five times more RNA in vitro than do corresponding nuclei from noninfected cells. Fifty percent of the RNA synthesized in vitro by nuclei from infected cells is vaccinia specific, and this vaccinia RNA synthesis is resistant to alpha-amanitin concentrations up to 100 micrograms/ml. Furthermore, when the RNA polymerase activities of these nuclei are separated on DEAE-Sephadex columns, 56% of the total nuclear enzyme activity is found to be the vaccinia-specific RNA polymerase known to be alpha-amanitin resistant. The nucleus associated vaccinia RNA polymerase represents 18% of the total cellular vaccinia RNA polymerase. This synthesis of vaccinia RNA in the nucleus may explain the nuclear requirement for vaccinia virus maturation.
D002451:Cell Compartmentation; D002467:Cell Nucleus / Q000201:enzymology; D002474:Cell-Free System; D012321:DNA-Directed RNA Polymerases / Q000378:metabolism; D006367:HeLa Cells / Q000166:cytology; D006801:Humans; D008274:Magnesium / Q000494:pharmacology; D008345:Manganese / Q000494:pharmacology; D009693:Nucleic Acid Hybridization; D012367:RNA, Viral / Q000096:biosynthesis; D014616:Vaccinia virus / Q000201:enzymology*; D014779:Virus Replication
D012367:RNA, Viral; D008345:Manganese; D012321:DNA-Directed RNA Polymerases; D008274:Magnesium